Core Viewpoint - The Portnoy Law Firm has initiated an investigation into potential securities fraud involving Encompass Health Corporation and may file a class action on behalf of investors [1]. Group 1: Investigation and Legal Actions - The Portnoy Law Firm is encouraging investors to contact them to discuss their legal rights and options for pursuing claims to recover losses [2]. - The firm offers a complimentary case evaluation for investors affected by the alleged corporate wrongdoing [2]. Group 2: Stock Performance and Allegations - Encompass Health's stock price dropped by $12.39, or 10.4%, closing at $107.28 per share on July 15, 2025, following allegations of poor performance on safety measures in for-profit hospitals [3]. - A New York Times article reported that Encompass's hospitals had "alarming mistakes" leading to patient fatalities and highlighted that 34 facilities had significantly worse rates of potentially preventable readmissions according to Medicare [3].
Encompass Health Corporation Investigated by the Portnoy Law Firm